Reduced In Vitro Clot Lysis and Release of More Active Platelet PAI-1 in Polycythemia Vera and Essential Thrombocythemia - Past and present a reflection of fifty years

By Posan E.   Ujj G.   Kiss A.   Telek B.   Rak K.   Udvardy M.  

Thrombosis Research, Vol. 90, Iss. 2, 1998-04 ,pp. : 51-56

Elsevier

Access to resources Recommend Favorite

Novel Oral Anticoagulants in the Management of Polycythemia Vera and Essential Thrombocythemia

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 26-28

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: A distinct aspirin-responsive and coumadin-resistant arterial thrombophilia

By Michiels Jan Jacques   Berneman Zwi   Schroyens Wilfried   Koudstaal Peter J.   Lindemans Jan   Neumann H. A. Martino   van Vliet Huub H. D. M.  

Platelets, Vol. 17, Iss. 8, 2006-12 ,pp. : 528-544

Informa Healthcare

Access to resources Recommend Favorite

Platelet refractoriness to classical agonists in a child with essential thrombocythemia

By Jaime-Perez Jose Carlos   Gomez-Almaguer David  

Platelets, Vol. 16, Iss. 1, 2005-02 ,pp. : 61-62

Informa Healthcare

Access to resources Recommend Favorite

Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment

By Reményi Gyula  

Platelets, Vol. 24, Iss. 6, 2013-09 ,pp. : 486-492

Informa Healthcare

Access to resources Recommend Favorite